国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

605507 国邦医药

午间休市 09-10 11:29:49

{"stockData":{"symbol":"605507","market":"SH","secType":"STK","nameCN":"国邦医药","latestPrice":23.47,"timestamp":1757474989000,"preClose":23.73,"halted":0,"volume":3203600,"delay":0,"changeRate":-0.011,"floatShares":302000000,"shares":559000000,"eps":1.4899,"marketStatus":"午间休市","change":-0.26,"latestTime":"09-10 11:29:49","open":23.61,"high":24.02,"low":23.38,"amount":75750200,"amplitude":0.027,"askPrice":23.46,"askSize":1,"bidPrice":23.43,"bidSize":5,"shortable":0,"etf":0,"ttmEps":1.4899,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1757480400000},"marketStatusCode":3,"adr":0,"adjPreClose":23.73,"symbolType":"stock","openAndCloseTimeList":[[1757467800000,1757475000000],[1757480400000,1757487600000]],"highLimit":26.1,"lowLimit":21.36,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":558823500,"isCdr":false,"pbRate":1.65,"roa":"--","peRate":15.752735,"roe":"5.61%","epsLYR":1.4,"committee":0.36036,"marketValue":13116000000,"turnoverRate":0.0106,"status":1,"floatMarketCap":7081000000},"requestUrl":"/m/hq/s/605507","defaultTab":"news","newsList":[{"id":"2565546904","title":"每周股票复盘：国邦医药（605507）回购股份537.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565546904","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565546904?lang=zh_cn&edition=full","pubTime":"2025-09-07 07:43","pubTimestamp":1757202189,"startTime":"0","endTime":"0","summary":"截至2025年9月5日收盘，国邦医药报收于23.58元，较上周的23.49元上涨0.38%。本周关注点公司公告汇总：国邦医药累计回购股份5,375,274股，占公司总股本的0.96%。公司公告汇总国邦医药关于股份回购进展公告：截至2025年8月31日，公司通过集中竞价交易方式累计回购股份5,375,274股，占公司总股本的0.96%，已支付总金额102,600,172.21元，实际回购价格区间为18.61元/股至19.88元/股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090700001694.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2561625845","title":"每周股票复盘：国邦医药（605507）引入浙资运营为战略投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2561625845","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561625845?lang=zh_cn&edition=full","pubTime":"2025-08-24 05:00","pubTimestamp":1755982844,"startTime":"0","endTime":"0","summary":"截至2025年8月22日收盘，国邦医药报收于23.12元，较上周的23.37元下跌1.07%。本周关注点公司公告汇总：国邦医药引入浙江省国有资本运营有限公司为持股5%以上股东。浙资运营承诺资金来源合法。截至报告签署日，浙资运营无未来12个月内进一步增减持计划。本次权益变动后，仕琦汇持股数量从50,021,196股减少至22,575,596股，持股比例从8.95%降至4.04%。本次转让还需经过上海证券交易所合规确认，并在中国证券登记结算有限责任公司上海分公司办理过户登记手续。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082400000912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2561767488","title":"国邦医药股价报23.07元 浙江国资战略入股6.85%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2561767488","media":"金融界","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561767488?lang=zh_cn&edition=full","pubTime":"2025-08-21 00:26","pubTimestamp":1755707160,"startTime":"0","endTime":"0","summary":"截至2025年8月20日收盘，国邦医药股价报23.07元，较前一交易日上涨0.65%。当日成交量为78588手，成交金额达1.79亿元。2024年年报显示，公司医药板块收入占比64.87%，动物保健品板块占比34.24%。8月20日晚间，国邦医药发布公告称，公司股东仕琦汇、洪德辉、庆世德合计向浙江省国有资本运营公司协议转让3830.63万股股份，占公司总股本的6.85%，转让价格为20.66元/股，总对价7.91亿元。转让完成后，浙江省国有资本运营公司将成为公司战略投资者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/21002652576547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2560103956","title":"国邦医药最新公告：股东协议转让股份引入战略投资者","url":"https://stock-news.laohu8.com/highlight/detail?id=2560103956","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560103956?lang=zh_cn&edition=full","pubTime":"2025-08-20 20:01","pubTimestamp":1755691279,"startTime":"0","endTime":"0","summary":"国邦医药公告称，公司持股5%以上股东仕琦汇、洪德辉及世庆德拟通过协议转让方式向国有运营公司转让其首次公开发行股票前持有的公司股份38,306,303股，占公司总股本的6.85%。此次权益变动不会导致公司控股股东及实际控制人发生变化。本次协议转让系转让方基于自身规划安排以及支持上市公司优化股权结构、引入认可公司价值和看好未来发展的战略投资者、推动上市公司战略发展，受让方国有运营公司基于对公司长期投资价值的认可而发生的股份变动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025082000039593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2560595195","title":"国邦医药收盘下跌1.80%，滚动市盈率15.38倍，总市值128.08亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2560595195","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2560595195?lang=zh_cn&edition=full","pubTime":"2025-08-19 19:26","pubTimestamp":1755602762,"startTime":"0","endTime":"0","summary":"8月19日，国邦医药今日收盘22.92元，下跌1.80%，滚动市盈率PE达到15.38倍，总市值128.08亿元。从行业市盈率排名来看，公司所处的化学制药行业市盈率平均65.78倍，行业中值37.53倍，国邦医药排名第45位。股东方面，截至2025年6月30日，国邦医药股东户数25030户，较上次减少973户，户均持股市值35.28万元，户均持股数量2.76万股。最新一期业绩显示，2025年半年报，公司实现营业收入30.26亿元，同比4.63%；净利润4.56亿元，同比12.60%，销售毛利率26.85%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/08/19192652542390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2559293721","title":"研报掘金丨华西证券：国邦医药后续动保弹性仍可期，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2559293721","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559293721?lang=zh_cn&edition=full","pubTime":"2025-08-14 15:37","pubTimestamp":1755157048,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK0239","BK1161","BK6100","CEP","BK1515","09939","BK6520","BK1574","002926","159938","605507","OTX.SI","BK0276"],"gpt_icon":0},{"id":"2558381586","title":"兽药概念盘中跳水，天康生物平盘","url":"https://stock-news.laohu8.com/highlight/detail?id=2558381586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558381586?lang=zh_cn&edition=full","pubTime":"2025-08-11 09:37","pubTimestamp":1754876233,"startTime":"0","endTime":"0","summary":"08月11日，兽药概念盘中跳水，截至09点37分，兽药概念整体指数下跌0.50%，报902.310点。从个股上来看，该概念的成分股中，天康生物平盘，国邦医药、傲农生物、*ST绿康跌幅居前。从资金上来看，截止发稿，兽药概念主力净流入为-1717.78万，其中天康生物受到资金热捧，主力净流入479.24万；拉长时间线来看，该板块近20日主力资金净流入-15.56亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811093713a6de8f3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250811093713a6de8f3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0238","605507","BK0028","BK0168","BK0201","BK0046","BK0195","603363","002100"],"gpt_icon":0},{"id":"2558006605","title":"每周股票复盘：国邦医药（605507）第一期员工持股计划锁定期届满","url":"https://stock-news.laohu8.com/highlight/detail?id=2558006605","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558006605?lang=zh_cn&edition=full","pubTime":"2025-08-10 05:08","pubTimestamp":1754773695,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：国邦医药第一期员工持股计划锁定期于2025年8月6日届满公司公告汇总国邦医药关于第一期员工持股计划锁定期届满的提示性公告。锁定期届满后，存续期内，员工持股计划管理委员会将根据市场情况处置股票。本员工持股计划将严格遵守市场交易规则，在公司年度报告、半年度报告公告前15日内等敏感期间不得买卖公司股票。公司将持续关注员工持股计划的实施进展，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025081000001132.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2557514285","title":"原料药上市公司财务总监PK：40岁及以下CFO占比26% 新诺威戴龙为业内最年轻CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2557514285","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557514285?lang=zh_cn&edition=full","pubTime":"2025-08-08 11:13","pubTimestamp":1754622780,"startTime":"0","endTime":"0","summary":"专题：专题|2024年度A股CFO数据报告：美的集团钟铮年薪946万，比亚迪周亚琳896万作为上市公司核心管理层关键成员，财务总监CFO的地位与作用至关重要。新浪财经《2024年度A股CFO数据报告》显示，2024年A股上市公司财务总监CFO群体薪酬规模合计达42.70亿元，平均年薪为81.48万元。其中，目前仍任职的最年轻的上市公司CFO年龄33岁，为新诺威的戴龙。从薪酬分布看，A股原料药公司CFO年薪平均值为66.12万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080811135494d6d68f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0191","BK0226","605507","BK0188","BK0028","600216","BK0239","300765"],"gpt_icon":0},{"id":"2557100673","title":"宠物产业升级加速 市场步入黄金发展期","url":"https://stock-news.laohu8.com/highlight/detail?id=2557100673","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557100673?lang=zh_cn&edition=full","pubTime":"2025-08-06 07:34","pubTimestamp":1754436881,"startTime":"0","endTime":"0","summary":"据中证报，宠物经济浪潮下，国内宠物食品龙头中宠股份于8月5日晚披露2025年半年报。公告显示，中宠股份业绩延续高增长态势，主粮业务爆发式增长与全球化产能布局成为核心驱动力。“随着年轻群体养宠渗透率提升和消费升级，宠物行业正从基础用品向主粮、健康服务等高端领域延伸，产业链上市公司集体受益。”业内人士表示，宠物经济已步入黄金发展期，但竞争加剧亦推动行业加速分化——产品研发、供应链整合与全渠道运营能力将成为企业突围关键。龙头公司凭借技术壁垒和全球化资源整合优势，有望在千亿赛道中持续领跑。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080607344197363b6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080607344197363b6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["600195","600655","600267","688621","603538","159831","600539","600826","BK0060","603566","BK0188","688526","688089","688298","605338","603387","603102","BK0028","603739","603955","603609","605507","603238","BK0239","600201","603182","605009"],"gpt_icon":0},{"id":"2557436628","title":"国邦医药：第一期员工持股计划锁定期届满，合计持有783.96万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2557436628","media":"公司公告","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557436628?lang=zh_cn&edition=full","pubTime":"2025-08-05 15:59","pubTimestamp":1754380769,"startTime":"0","endTime":"0","summary":"国邦医药公告，公司第一期员工持股计划锁定期将于2025年8月6日届满。该计划通过二级市场买入及回购专户非交易过户方式累计持有783.96万股，占总股本1.40%。存续期为24个月，锁定期12个月，届满后将依据相关规定和市场情况处置股票，并遵守敏感期交易限制。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160903a6d40a34&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805160903a6d40a34&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2556425803","title":"兽药概念盘中拉升，利民股份涨4.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556425803","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556425803?lang=zh_cn&edition=full","pubTime":"2025-08-04 14:43","pubTimestamp":1754289830,"startTime":"0","endTime":"0","summary":"08月04日，兽药概念盘中拉升，截至14点43分，兽药概念整体指数上涨1.02%，报900.750点。从个股上来看，该概念的成分股中，利民股份涨4.83%，国邦医药、生物股份、金河生物涨幅居前。从资金上来看，截止发稿，兽药概念主力净流入为9635.40万，其中利民股份受到资金热捧，主力净流入1.05亿；拉长时间线来看，该板块近20日主力资金净流入-16.46亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804144350a6d1b761&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804144350a6d1b761&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0186","605507","BK0229","600201","BK0070","002734","BK0239"],"gpt_icon":0},{"id":"2556874269","title":"合成生物概念盘中拉升，国邦医药涨2.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556874269","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556874269?lang=zh_cn&edition=full","pubTime":"2025-08-04 09:42","pubTimestamp":1754271761,"startTime":"0","endTime":"0","summary":"08月04日，合成生物概念盘中拉升，截至09点42分，合成生物概念整体指数上涨0.70%，报1301.850点。从个股上来看，该概念的成分股中，国邦医药涨2.60%，金河生物、*ST绿康、朗坤科技涨幅居前。从资金上来看，截止发稿，合成生物概念主力净流入为-2.18亿，其中博瑞医药受到资金热捧，主力净流入5623.14万；拉长时间线来看，该板块近20日主力资金净流入-140.45亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094241a6d13696&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250804094241a6d13696&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2556468826","title":"每周股票复盘：国邦医药（605507）股东户数减少，业绩稳步增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2556468826","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556468826?lang=zh_cn&edition=full","pubTime":"2025-08-03 01:44","pubTimestamp":1754156650,"startTime":"0","endTime":"0","summary":"截至2025年8月1日收盘，国邦医药报收于23.5元，较上周的21.45元上涨9.56%。本周关注点股本股东变化：截至2025年6月30日公司股东户数为2.5万户，较3月31日减少973户业绩披露要点：2025年中报显示，公司主营收入30.26亿元，同比上升4.63%公司公告汇总：审议通过《关于2025年半年度报告及摘要的议案》股本股东变化近日国邦医药披露，截至2025年6月30日公司股东户数为2.5万户，较3月31日减少973.0户，减幅为3.74%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025080300000209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605507"],"gpt_icon":0},{"id":"2556682523","title":"国邦医药上市4周年：归母净利润增长10.70%，市值较峰值蒸发50.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556682523","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556682523?lang=zh_cn&edition=full","pubTime":"2025-08-02 05:16","pubTimestamp":1754082960,"startTime":"0","endTime":"0","summary":"国邦医药自2021年8月2日上市至今，已迎来4周年。从上市首日收盘价为46.9元、市值262.09亿元，到如今市值达到131.32亿元。截至最新完整财年的2024年，公司实现7.82亿元的归母净利润，近年累计增长了10.70%。这4年间，国邦医药无一年份出现亏损。2021年8月3日，国邦医药的市值巅峰达到267.68亿元，股价也顺应升至47.9元。而至8月1日收盘，国邦医药的股价为23.5元，市值为131.32亿元，相比峰值时期市值减少136.35亿元，市值蒸发了50.94%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080222380594cb2c9f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080222380594cb2c9f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605507"],"gpt_icon":0},{"id":"2556899973","title":"国邦医药：累计回购0.96%公司股份，耗资1.03亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556899973","media":"21世纪经济报道","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556899973?lang=zh_cn&edition=full","pubTime":"2025-08-01 16:00","pubTimestamp":1754035200,"startTime":"0","endTime":"0","summary":"南方财经8月1日电，国邦医药公告，截至2025年7月31日，公司通过集中竞价交易方式累计回购股份537.53万股，占公司总股本的比例为0.96%，成交的最高价为19.88元/股，最低价为18.61元/股，已支付的总金额为1.03亿元（不含交易费用）。此次回购资金总额在1亿元至2亿元之间，回购价格不超过25元/股，回购期限为2025年3月11日至2026年3月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801160109972c58e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801160109972c58e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["605507","BK0239"],"gpt_icon":0},{"id":"2556861164","title":"研报掘金丨开源证券：国邦医药估值性价比高，维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2556861164","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556861164?lang=zh_cn&edition=full","pubTime":"2025-08-01 13:51","pubTimestamp":1754027479,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","605507","BK1161","BK0239","BK1574","BK1515","CEP","159938","09939","161022","688221"],"gpt_icon":0},{"id":"2556694558","title":"原料药上市公司董秘PK：赛分科技王中蕾任董秘不足一年 年仅30岁已收获超150万年薪","url":"https://stock-news.laohu8.com/highlight/detail?id=2556694558","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556694558?lang=zh_cn&edition=full","pubTime":"2025-08-01 12:57","pubTimestamp":1754024241,"startTime":"0","endTime":"0","summary":"新浪财经《2024年度A股董秘数据报告》显示，2024年A股上市公司董秘薪酬合计达40.86亿元，平均年薪75.43万元。其中，最年轻的上市公司董秘年仅30岁，为赛分科技的王中蕾。从董秘的学历分布看，本科学历董秘超过半数。从薪酬分布看，A股原料药上市公司董秘年薪平均值为60.84万元。从任职年限看，五位最高薪董秘分别于公司任职5年、不足1年、5年、8年、不足2年。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801125730972bf774&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801125730972bf774&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","603229","605507","603351","688166","605116","605177","600216","603538","688758","BK0239"],"gpt_icon":0},{"id":"2556868258","title":"兽药概念盘中拉升，金河生物涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2556868258","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556868258?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:42","pubTimestamp":1754012524,"startTime":"0","endTime":"0","summary":"08月01日，兽药概念盘中拉升，截至09点42分，兽药概念整体指数上涨1.05%，报897.950点。从个股上来看，该概念的成分股中，金河生物涨5.05%，国邦医药、华神科技、瑞普生物涨幅居前。从资金上来看，截止发稿，兽药概念主力净流入为284.03万，其中金河生物受到资金热捧，主力净流入1612.25万；拉长时间线来看，该板块近20日主力资金净流入-15.82亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094204972b8f5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094204972b8f5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["002688","605507","BK0239"],"gpt_icon":0},{"id":"2555588798","title":"7月31日26股被评买入评级！宁德时代上涨空间超60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555588798","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555588798?lang=zh_cn&edition=full","pubTime":"2025-07-31 19:26","pubTimestamp":1753961203,"startTime":"0","endTime":"0","summary":"东方财富Choice数据显示，截至7月31日19点，当天有26股被券商评为买入评级，包括宁德时代、药明康德、九号公司、长江电力、首旅酒店等股票。部分股票被多家券商评为买入评级，宁德时代、药明康德被3家券商评为买入评级，国邦医药、极米科技、苏试试验被2家券商评为买入评级。从部分个股券商给出的目标价来看，宁德时代上涨空间超60%，苏试试验上涨空间超过40%。机构目标价涨幅前20以近一月券商研报为样本，按机构目标价（有多家券商给出目标价的，取最大值）和最新收盘价相比，截至7月31日收盘，长城汽车上涨空间最大，为98.92%。文章来源：东方财富研究中心","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073119380494c62170&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073119380494c62170&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688696","600258","605507","603259","689009","02359","300750"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1757477648117,"stockEarnings":[{"period":"1week","weight":0.0326},{"period":"1month","weight":0.0282},{"period":"3month","weight":0.1752},{"period":"6month","weight":0.2523},{"period":"1year","weight":0.29},{"period":"ytd","weight":0.1724}],"compareEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":0.0474},{"period":"3month","weight":0.119},{"period":"6month","weight":0.1336},{"period":"1year","weight":0.3913},{"period":"ytd","weight":0.1359}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"国邦医药集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"25030人(较上一季度减少3.74%)","perCapita":"12054股","listingDate":"2021-08-02","address":"浙江省绍兴市新昌县省级高新技术产业园区兴梅大道60号","registeredCapital":"55882万元","survey":"　　国邦医药集团股份有限公司的主营业务是医药及动物保健品领域相关产品的研发、生产和销售。公司的主要产品是医药原料药和制剂、关键医药中间体、动物保健品。公司先后荣获“中国化学制药行业工业企业综合实力百强企业”、全国工商联医药业商会“中国医药工业百强企业”、中国医药保健品进出口商会“中国西药原料行业会员企业出口十强”、“优秀院士专家工作站”、全国工商联医药业商会“2023-2024年度制药工业营业收入前百家企业”等荣誉称号。","listedPrice":32.57},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.9","shortVersion":"4.34.9","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"国邦医药,605507,国邦医药股票,国邦医药股票老虎,国邦医药股票老虎国际,国邦医药行情,国邦医药股票行情,国邦医药股价,国邦医药股市,国邦医药股票价格,国邦医药股票交易,国邦医药股票购买,国邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"国邦医药(605507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供国邦医药(605507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}